Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Dai Maruyama, Kensei Tobinai, Shinichi Makita, Takashi Ishida, Shigeru Kusumoto, Kenji Ishitsuka, Makoto Yoshimitsu, Yoshitaka Imaizumi, Yasushi Sawayama, Shogo Takeuchi, Atae Utsunomiya, Kunihiro Tsukasaki, Sumiaki Fujitani, Kazushi Araki | ||||||||||||
Title | First-in-Human Study of the EZH1/2 Dual Inhibitor DS-3201b in Patients with Relapsed or Refractory Non-Hodgkin Lymphomas — Preliminary Results | ||||||||||||
|
|||||||||||||
URL | http://www.bloodjournal.org/content/130/Suppl_1/4070?sso-checked=true | ||||||||||||
Abstract Text | Blood Dec 2017, 130 (Suppl 1) 4070 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|